Literature DB >> 32099298

Pathological fracture of the femur in Alagille Syndrome: A case report.

Made Agus Maharjana1, I Ketut Suyasa1, I Ketut Siki Kawiyana1, Hans Kristian Nugraha1.   

Abstract

Alagille Syndrome is a rare autosomal dominant genetic disorder, occur only 1:70,000 in population, and characterized by reduced interlobular bile ducts, and resultant nutritional deficiencies associated with the inability to absorb fat-soluble vitamins such as vitamin D. Patients are at risk for secondary osteoporosis, rickets/osteomalacia, and ultimately may result in fracture. The majority of patients suffer from chronic cholestasis, which can have a variety of adverse effects on bone metabolism. Hypothyroidism has been described in some Alagille Syndrome patients, and eventually delayed puberty can occur. Two until fourteen percents of patients of Alagille syndrome will suffer from fractures, in which it primarily occurs in the lower limb long bones in the absence of significant trauma. This study aimed to present a rare case of pathological fracture of femur in Alagille syndrome patient and its management in our hospital. Six-year-old male with pain on his right thigh came to our ER after fell down while putting on his pants. He had been diagnosed with biliary atresia at the age of 3 months and underwent surgical bile duct reconstruction. In addition, he also suffered from congenital hypothyroidism and consequently, stunted growth. The pathological fracture of the femur was treated conservatively with hemispica cast. At 2 months follow up, there is already radiographic evidence of fracture healing occurred by secondary intention and callus formation. By ensuring adequate calcium and vitamin D intake, monitoring for vitamin D deficiency, monitoring for fragility fractures, and avoiding trauma-related accidents, a proper conservative treatment using hemispica cast could still always be considered for managing such diaphyseal fractures in Alagille syndrome, especially in relatively low-resource countries such as Indonesia.
© 2019 Delhi Orthopedic Association. All rights reserved.

Entities:  

Keywords:  Alagille syndrome; Cholestatic liver disease; Congenital hypothyroidism; Fracture; Osteomalacia

Year:  2019        PMID: 32099298      PMCID: PMC7026569          DOI: 10.1016/j.jcot.2019.12.009

Source DB:  PubMed          Journal:  J Clin Orthop Trauma        ISSN: 0976-5662


  6 in total

1.  AAOS Clinical Practice Guideline on the Treatment of Pediatric Diaphyseal Femur Fractures.

Authors:  David S Jevsevar; Kevin G Shea; Jayson N Murray; Kaitlyn S Sevarino
Journal:  J Am Acad Orthop Surg       Date:  2015-10-27       Impact factor: 3.020

2.  Clinical utility gene card for: Alagille Syndrome (ALGS).

Authors:  Laura D Leonard; Grace Chao; Alastair Baker; Kathleen Loomes; Nancy B Spinner
Journal:  Eur J Hum Genet       Date:  2013-07-24       Impact factor: 4.246

3.  Alagille Syndrome: A Novel Mutation in JAG1 Gene.

Authors:  Rita Fischetto; Viviana V Palmieri; Maria E Tripaldi; Alberto Gaeta; Angela Michelucci; Maurizio Delvecchio; Ruggiero Francavilla; Paola Giordano
Journal:  Front Pediatr       Date:  2019-05-15       Impact factor: 3.418

Review 4.  Alagille Syndrome and the Liver: Current Insights.

Authors:  Shivaram P Singh; Girish K Pati
Journal:  Euroasian J Hepatogastroenterol       Date:  2019-02-01

5.  Pathological fracture of the femur in Alagille syndrome that was treated with low-intensity pulsed ultrasound stimulation and an Ilizarov ring fixator: a case report.

Authors:  Koji Nozaka; Yoichi Shimada; Naohisa Miyakoshi; Shin Yamada; Yuji Kasukawa; Atsuko Noguchi
Journal:  BMC Musculoskelet Disord       Date:  2014-07-08       Impact factor: 2.362

6.  Systematic Review: The Epidemiology, Natural History, and Burden of Alagille Syndrome.

Authors:  Binita M Kamath; Alastair Baker; Roderick Houwen; Lora Todorova; Nanda Kerkar
Journal:  J Pediatr Gastroenterol Nutr       Date:  2018-08       Impact factor: 2.839

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.